Evidence map›Paper›PMID 34556886›Full record

ArticleNature immunology2021

OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity.

Ashley S Doane, Chi-Shuen Chu, Dafne Campigli Di Giammartino, Martín A Rivas, Johannes C Hellmuth, Yanwen Jiang, Nevin Yusufova, Alicia Alonso, Robert G Roeder, Effie Apostolou and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Ashley S DoaneCaryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-1489-1786
Chi-Shuen ChuThe Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY, USA.
Dafne Campigli Di GiammartinoDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Martín A RivasDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-9603-6897
Johannes C HellmuthDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Yanwen JiangCaryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Nevin YusufovaDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Alicia AlonsoDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Robert G RoederThe Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY, USA.
Effie ApostolouDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Ari M MelnickDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. amm2014@med.cornell.edu.ORCID http://orcid.org/0000-0002-8074-2287
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA. ole2001@med.cornell.edu.ORCID http://orcid.org/0000-0002-8061-9617
Cornell University · USRockefeller University · US

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
The impact of changes in chromatin architecture on cancer phenotypes and tumor progressionP01CA229086 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Aristotelis Tsirigos · 2019 to 2026
$17.0M
Targeting Epigenetic Circuits in B-Cell LymphomasR35CA220499 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MELNICK, ARI M. · 2018 to 2024
$7.2M
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesisR01AI148387 · NIAID · ROCKEFELLER UNIVERSITY · PI ROEDER, ROBERT G · 2020 to 2024
$3.7M
Transcriptional regulatory mechanisms in B cell development and leukemogenesisR01CA178765 · NCI · ROCKEFELLER UNIVERSITY · PI ROEDER, ROBERT G · 2013 to 2017
$2.8M
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma (Administrative Supplement)R01CA194547 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELEMENTO, OLIVIER, TAM, WAYNE · 2015 to 2019
$2.6M
Use of chromatin accessibility maps to discover novel regulatory circuits in aggressive B cell lymphomasF31CA220981 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DOANE, ASHLEY STEPHEN · 2017 to 2018
$89k
NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002384NCI NIH HHS F31 CA220981NCI NIH HHS P01 CA229086NCI NIH HHS R01 CA178765NCI NIH HHS R01 CA194547NCI NIH HHS R35 CA220499NIAID NIH HHS R01 AI148387
6 · The paper itself

Abstract

During the germinal center (GC) reaction, B cells undergo profound transcriptional, epigenetic and genomic architectural changes. How such changes are established remains unknown. Mapping chromatin accessibility during the humoral immune response, we show that OCT2 was the dominant transcription factor linked to differential accessibility of GC regulatory elements. Silent chromatin regions destined to become GC-specific super-enhancers (SEs) contained pre-positioned OCT2-binding sites in naive B cells (NBs). These preloaded SE 'seeds' featured spatial clustering of regulatory elements enriched in OCT2 DNA-binding motifs that became heavily loaded with OCT2 and its GC-specific coactivator OCAB in GC B cells (GCBs). SEs with high abundance of pre-positioned OCT2 binding preferentially formed long-range chromatin contacts in GCs, to support expression of GC-specifying factors. Gain in accessibility and architectural interactivity of these regions were dependent on recruitment of OCAB. Pre-positioning key regulators at SEs may represent a broadly used strategy for facilitating rapid cell fate transitions.

Indexed as

AnimalsB-LymphocytesCell DifferentiationChromatinEpigenomicsFemaleGenomicsGerminal CenterImmunity, HumoralMaleMiceMice, Inbred C57BLOrganic Cation Transporter 2Protein DomainsTranscription FactorsChromatinOrganic Cation Transporter 2Slc22a2 protein, mouseTranscription Factors

Identifiers

PMID34556886
PMCPMC9829245
OpenAlexW3200915573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.